Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocardial Reperfusion Injury | 6 | 2016 | 17 | 1.750 |
Why?
|
| Resuscitation | 3 | 2015 | 65 | 1.270 |
Why?
|
| Heart Valve Prosthesis | 3 | 2015 | 55 | 0.660 |
Why?
|
| Swine | 7 | 2016 | 215 | 0.590 |
Why?
|
| Bioprosthesis | 2 | 2015 | 58 | 0.580 |
Why?
|
| Glycoproteins | 1 | 2015 | 45 | 0.510 |
Why?
|
| Antibodies | 1 | 2015 | 52 | 0.510 |
Why?
|
| Antigens, CD | 1 | 2015 | 103 | 0.500 |
Why?
|
| Bioengineering | 1 | 2015 | 70 | 0.500 |
Why?
|
| Peptides | 1 | 2015 | 120 | 0.490 |
Why?
|
| Heart Valves | 2 | 2011 | 16 | 0.490 |
Why?
|
| Atmospheric Pressure | 2 | 2013 | 10 | 0.470 |
Why?
|
| Tissue Scaffolds | 1 | 2015 | 415 | 0.410 |
Why?
|
| Tissue Engineering | 3 | 2011 | 656 | 0.380 |
Why?
|
| Animals | 12 | 2016 | 7541 | 0.330 |
Why?
|
| Myocardial Ischemia | 1 | 2010 | 107 | 0.330 |
Why?
|
| Disease Models, Animal | 4 | 2016 | 1022 | 0.240 |
Why?
|
| Sheep | 3 | 2015 | 233 | 0.240 |
Why?
|
| Fructose | 1 | 2003 | 11 | 0.230 |
Why?
|
| Myocytes, Cardiac | 2 | 2013 | 86 | 0.200 |
Why?
|
| Myocardial Infarction | 3 | 2013 | 475 | 0.190 |
Why?
|
| Time Factors | 4 | 2016 | 2149 | 0.180 |
Why?
|
| Peroxidase | 2 | 2015 | 31 | 0.180 |
Why?
|
| Bioreactors | 2 | 2010 | 60 | 0.170 |
Why?
|
| Myocardium | 2 | 2015 | 186 | 0.140 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2016 | 11 | 0.140 |
Why?
|
| Fluid Shifts | 1 | 2016 | 2 | 0.140 |
Why?
|
| Extracellular Fluid | 1 | 2016 | 11 | 0.140 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2016 | 56 | 0.130 |
Why?
|
| Edema, Cardiac | 1 | 2016 | 13 | 0.130 |
Why?
|
| Blood Transfusion | 1 | 2016 | 73 | 0.130 |
Why?
|
| Vimentin | 1 | 2015 | 10 | 0.130 |
Why?
|
| Actins | 1 | 2015 | 51 | 0.130 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2015 | 35 | 0.130 |
Why?
|
| beta Catenin | 1 | 2015 | 37 | 0.130 |
Why?
|
| Prosthesis Design | 1 | 2015 | 97 | 0.130 |
Why?
|
| Regional Blood Flow | 1 | 2015 | 86 | 0.130 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2015 | 53 | 0.130 |
Why?
|
| Heart | 1 | 2016 | 177 | 0.120 |
Why?
|
| Echocardiography | 1 | 2015 | 159 | 0.120 |
Why?
|
| Endocardium | 1 | 2013 | 3 | 0.120 |
Why?
|
| Extracellular Matrix | 1 | 2016 | 245 | 0.120 |
Why?
|
| Myocardial Reperfusion | 1 | 2013 | 10 | 0.120 |
Why?
|
| Coronary Vessels | 1 | 2015 | 165 | 0.120 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 538 | 0.110 |
Why?
|
| Cells, Cultured | 2 | 2016 | 833 | 0.110 |
Why?
|
| Pericardium | 1 | 2013 | 52 | 0.110 |
Why?
|
| Insulin Resistance | 2 | 2006 | 462 | 0.100 |
Why?
|
| Biomedical Engineering | 1 | 2011 | 26 | 0.100 |
Why?
|
| Female | 4 | 2016 | 19959 | 0.100 |
Why?
|
| Apoptosis | 1 | 2013 | 360 | 0.100 |
Why?
|
| Heterocyclic Compounds | 1 | 2010 | 12 | 0.090 |
Why?
|
| Organometallic Compounds | 1 | 2010 | 23 | 0.090 |
Why?
|
| Cell Death | 1 | 2010 | 77 | 0.090 |
Why?
|
| Doxorubicin | 1 | 2010 | 82 | 0.090 |
Why?
|
| Cardiomyopathies | 1 | 2010 | 56 | 0.090 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2010 | 74 | 0.090 |
Why?
|
| Contrast Media | 1 | 2010 | 138 | 0.090 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2010 | 170 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 1328 | 0.080 |
Why?
|
| Rats, Zucker | 2 | 2006 | 5 | 0.080 |
Why?
|
| Endothelial Cells | 1 | 2009 | 189 | 0.080 |
Why?
|
| Rats | 3 | 2010 | 1595 | 0.070 |
Why?
|
| Ischemic Preconditioning, Myocardial | 1 | 2006 | 3 | 0.070 |
Why?
|
| Insulin | 1 | 2003 | 367 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2003 | 743 | 0.050 |
Why?
|
| Diet | 1 | 2003 | 391 | 0.050 |
Why?
|
| Blood Glucose | 1 | 2003 | 494 | 0.050 |
Why?
|
| Obesity | 1 | 2006 | 1175 | 0.040 |
Why?
|
| Diffusion | 1 | 2016 | 13 | 0.030 |
Why?
|
| Water-Electrolyte Balance | 1 | 2016 | 16 | 0.030 |
Why?
|
| Cell Shape | 1 | 2016 | 28 | 0.030 |
Why?
|
| Osmotic Pressure | 1 | 2016 | 10 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2016 | 46 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2016 | 114 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2016 | 40 | 0.030 |
Why?
|
| Kinetics | 1 | 2016 | 209 | 0.030 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2016 | 73 | 0.030 |
Why?
|
| Preoperative Care | 1 | 2016 | 114 | 0.030 |
Why?
|
| Male | 3 | 2010 | 19165 | 0.030 |
Why?
|
| Gadolinium | 1 | 2010 | 22 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2010 | 62 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2009 | 92 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2010 | 245 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 876 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2010 | 348 | 0.020 |
Why?
|
| Decanoic Acids | 1 | 2006 | 1 | 0.020 |
Why?
|
| Diazoxide | 1 | 2006 | 1 | 0.020 |
Why?
|
| KATP Channels | 1 | 2006 | 1 | 0.020 |
Why?
|
| Hydroxy Acids | 1 | 2006 | 2 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2006 | 30 | 0.020 |
Why?
|
| Potassium Channel Blockers | 1 | 2006 | 9 | 0.020 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2006 | 9 | 0.020 |
Why?
|
| Mitochondria, Heart | 1 | 2006 | 17 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2006 | 51 | 0.020 |
Why?
|
| Mitochondrial Membranes | 1 | 2006 | 21 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2006 | 45 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2006 | 81 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 2006 | 62 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 263 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2006 | 157 | 0.020 |
Why?
|
| Humans | 1 | 2010 | 32005 | 0.000 |
Why?
|